Saturday, 24 Oct, 6.55 pm India Herald Group

Here is When India's COVID-19 Vaccine Coming

India's Ingenuously developed COVID-19 Vaccine, Covaxin is all set to enter the third phase. The Drug Controller General of india (DGCA) recently gave permission for the third phase trial on 26,000 participants in 25 centers across the country.

Covaxin is being indigenously developed by Bharat Biotech, the firm in collaboration with the indian Council of Medical Research (ICMR). Bharat Biotech plans to test over 20,000 volunteers across 12-14 states in India. Sai Prasad, executive director of the company says that the vaccine is likely to be out only in june 2021, if everything goes as per the plan. "If we get all the approvals in place, I think during Q2 of 2021, we should get the efficacy readout from our phase 3 clinical trial - april, May, june, for example. That is for the full efficacy results," prasad says.

In the third phase testing, the tests will be carried out in various hospitals in major cities. Willing Symptomatic patients with confirmed CT scans and chest X-rays will be given the vaccine dose. As a part of the trial, two doses will be imparted - 0.5 ml on day zero and day 28.

Theaters to Open in Vijayawada

Mahesh Babu's First Holiday After Lockdown Break

Young Hero Back To Work After Lockdown

Pooja Hegde Pauses Signing Telugu Films?

Small Actor Signs His First Brand Deal

Source: India Herald - Nimisha
Disclaimer: This story is auto-aggregated by a computer program and has not been created or edited by Dailyhunt. Publisher: ApHerald